Abeona Therapeutics Inc. (NASDAQ:ABEO)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $25.5M
- Net income
- -$62.9M
- Net margin
- -246.4%
Little or no net debt.
- Total debt
- $19.9M
- Cash
- $56.2M
- Debt / equity
- 0.16
Comfortably covers what is due within a year.
- Current assets
- $164.6M
- Current liabilities
- $24.8M
- Current ratio
- 6.63
Consumes cash and must keep raising it.
- Operating cash flow
- -$76.4M
- Free cash flow
- -$81.5M
- FCF margin
- -319.5%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 57.0M
- Share growth (1y)
- 8.6%
- Cash runway
- 9 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ABEO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 11.38 M | 8.72 M | 5.42 M | 0.00 | 400.00 K | 0.00 |
| Revenue Growth (YoY) | 2745.00 % | — | — | — | — | — |
| Cost of Revenue | 4.18 M | 3.56 M | 2.84 M | 488.00 K | 100.00 K | 0.00 |
| Gross Profit | 7.20 M | 5.16 M | 2.58 M | -488.00 K | 300.00 K | 0.00 |
| SG&A Expense | 15.84 M | 18.63 M | 18.78 M | 19.31 M | 17.15 M | 9.79 M |
| R&D Expense | 5.02 M | 9.55 M | 6.71 M | 4.22 M | 5.94 M | 9.94 M |
| Operating Expenses | 20.86 M | 28.19 M | 25.49 M | 23.53 M | 23.09 M | 19.73 M |
| Operating Income | -13.65 M | -23.03 M | -22.91 M | -24.02 M | -22.79 M | -19.73 M |
| Pretax Income | -20.19 M | -17.07 M | -20.68 M | -20.36 M | 124.34 M | -12.03 M |
| Tax Provision | 0.00 | 2.00 K | -215.00 K | -15.20 M | 15.51 M | 0.00 |
| Net Income | -20.19 M | -17.07 M | -20.46 M | -5.16 M | 108.83 M | -12.03 M |
| EPS (Basic) | -0.35 | -0.30 | -0.39 | -0.10 | 2.07 | -0.24 |
| EPS (Diluted) | -0.35 | -0.30 | -0.36 | -0.10 | 1.71 | -0.24 |
| Shares Outstanding | 57.05 M | 56.62 M | 52.95 M | 54.24 M | 52.52 M | 49.78 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.